Bavarian Nordic — Maj 2021
-
Link til Børsen, men oprindelig fra finans.dk: https://borsen.dk/nyheder/politik/regeringen-forbereder-investering-i-udvikling-af-coronavaccine-fra-bavarian-nordic
-
Og så er det også kort nævnt her: https://borsen.dk/nyheder/markedsberetninger/for-markedet-aabner-nedjusteret-maersk-anbefaling-og-vigende-kurser
-
Men ja, underligt at det ikke har givet anledning til at flere medier skriver om det. Om ikke andet så plejer et fald på minus 6%, men hvor aktien ender i plus, at blive bemærket.
-
Bavarian: Det forlyder fra forsøgene i Holland, at test-grupperne 4-7 gennemføres uden adjuvans. Det bliver spændende at høre nærmere detaljer, når der foreligger resultater. Hvis finansiering skal på plads før regeringen går på sommerferie, skal der snart meldes noget ud..
-
@Pensionisten - ja, nu må vi se
-
In 2021, Zealand Pharma expects revenue from existing license agreements. However, since such revenue is uncertain in terms of size and timing, Zealand Pharma does not intend to provide guidance on such revenue.
Net operating expenses in 2021 are expected to be DKK 1,250 million +/-10%. -
CC kl. 16.00:
https://edge.media-server.com/mmc/p/3v88gxa
1. kvt. 2021, plus det løse Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind